Symposium U.S.-China Life Science Industry Collaborations

New Haven, CT
Tuesday, June 22, 2010

Online registration closes on Sunday, June 20, 2010 at 7 pm.  After that it will be pay by check or credit card (Visa or Mastercard) at the door.

There will be a 30% surcharge on all tickets for pay at the door.


Symposium on U.S.A.-China Life Science Industry Collaborations

June 22, 2010
Symposium:  9:00 am -  5:00 pm
Reception and Banquet: 5:30 - 8:30 pm

Yale University
Woolsey Hall, Presidents Room


9:00-9:15           Welcome to Connecticut and Overview of Connecticut Bioscience – Joan McDonald

Joan McDonald is Commissioner of the Department of Economic and Community Development for the State of Connecticut.

9:15-9:30           Connecticut/Chinese Bioscience Collaboration –

                        Paul Pescatello, J.D., Ph.D.

Paul Pescatello is President/CEO of Connecticut United for Research Excellence (CURE).  CURE is a statewide, member-supported coalition of more than 100 educational and research institutions, biotechnology and pharmaceutical companies, and other supporting businesses. Its mission is to build networks and critical mass for the industry within the state, to keep Connecticut competitive in bioscience, and to tell the Connecticut BioScience story.

9:30-9:50           Yale University Technology Transfer – Jon Soderstrom, Ph.D.

Dr. Soderstrom is currently the Managing Director of the Office of Cooperative Research at Yale University.  The Office manages the intellectual assets created at Yale to achieve the maximum benefit for the public and provide a financial return to support the University’s research efforts.

9:50-10:30         China Overview –  Nancy Yao Maasbach, MBA

Nancy Yao Maasbach is the first Chinese-American to serve as Executive Director of the Yale-China Association. Highlights of her career include several years with Goldman Sachs in Hong Kong and New York, where she served as Vice President (Investment Banking and Executive Office) and as Director of Policy Research (Global Markets Institute) and time as the Director of Asia at the Center for Financial Research and Analysis. Nancy was an Associate Producer at CNN during the Handover Coverage of Hong Kong to the People’s Republic of China in 1997. Nancy continues her ongoing research on U.S.-China relations, especially the role Chinese-Americans play in building ties. She received an MBA from the Yale School of Management.

10:30-10:45       Break

10:45-11:30       Overview of Chinese Biotech Industry: now and next 5 years –  

                        Hongjian Ma

Mr. Hongjian Ma is Deputy Director of the China National Center for Biotechnology Development (CNCBD). CNCBD is an organization under the Ministry of Science and Technology, and is the sole national center to coordinate and implement the national science & technology program in Biotechnology. CNCBD is responsible for most of the national government support to the innovation in the biotech industry, through fundings such as 863 (since 1987) and National Innovation Grant—Drug Innovation, and through establishment of local biotech centers.

11:30-12:15       Government and University Relationship to Biotech Industry Development

Introduction by Yuguo Zheng, Head of Biologics Division, China National Center for Biotechnology Development (CNCBD)

China Medical City, Dalian Biotech Park,Yantai Biotech Park, Wuhan Biotech Park, New SummitBio

12:15-1:35         Lunch break

1:35-2:15           Chinese Biological Products, past, current and future –

                         Xiaoming Yang

Dr. Xiaoming Yang is chief executive offider of the China Biologics Group, the largest vaccine company in China.  Each of the seven subsidiaries is itself one of the largest vaccine companies in China: Wuhan, Shanghai, Changchun, Beijing, Lanzhou, Chengdu Institute of Biologics, and a public company Tiantan.

2:15-2:30           Break

2:30-3:45           United States-China Collaboration Case Studies

W. Roy Hua, Ph.D., Partner, Columbus Growth Partners—Moderator

Yiyou Chen, Ph.D., Chief Scientific Officer, CrownBio, Headquartered in California, CrownBio has wholly owned research facilities in Beijing and Taicang, China and in Indianapolis.

D. Terence Jones J.D., Partner, Wiggin and Dana

Dr. Sam Liao, Director, Asia Business Development, Novartis

3:30-5:00           Cutting-edge Biotech Developments in the United States and China

Paul Pescatello, Moderator

Dr. Wei Han, Executive Deputy Director, Stem Cell Center, Shanghai Jiaotong University

Dr. Haifan Lin Ph.D.,  Professor of Cell Biology, Yale School of Medicine, Director of Yale Stem Cell Center

Harry H. Penner, Jr., Chairman of New Haven Pharmaceuticals and former Chair of Rhei Pharmaceuticals

Michael Schmertzler, Kolltan Pharmaceuticals

Dr. Lin Wang, CEO, BioTrand and Executive Board Director, BioSino Bio-technology and Science  

5:00                  Closing Remarks

5:30 - 8:30 pm   Reception and Banquet (Tickets additional.)


Contact Information

  • Questions?  Email:

Payment Instructions

  • Admission:  $75*
    $50* for CURE / NYBA members / MassBio and the Yale Community.
    $30* for students and postdocs (includes lunch)
    * Plus service charge of $3

    Networking Reception and Banquet at Yale on June 22
    $100 per person

© 2018
Quick, easy and affordable online event registration and event management software for all event sizes.